Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:08 AM
Ignite Modification Date:
2025-12-25 @ 5:08 AM
NCT ID:
NCT05416827
Eligibility Criteria:
Inclusion Criteria:
* patients with a visually significant (BCVA\<20/50) idiopathic epiretinal membrane.
* ocular axial length less than 27.00 mm (optical biometry) associated with cataracts.
Exclusion Criteria:
* concomitant or previous macular diseases (diabetic macular edema, retinal vein occlusion and agerelated macular degeneration).
* secondary epiretinal membrane, other visually significant macular pathology and prior intravitreal triamcinolone acetonide injection.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05416827
Study Brief:
Protocol Section:
NCT05416827